Traumatic brain injury (TBI) triggers widespread metabolic reprogramming across multiple central nervous system cell types, including neurons, astrocytes, and microglia. Despite recognition that cerebral metabolism shifts after injury, the spatial and temporal organization of these responses across neuroglial compartments is incompletely defined. Because pyruvate occupies a central metabolic junction—linking glycolysis, lactate metabolism, and the tricarboxylic acid (TCA) cycle—tracking pyruvate-derived metabolites can reveal pathway-specific flux changes during secondary injury.
This study combined metabolic flux tracing using in vivo administration of isotopically labeled pyruvate with high-resolution matrix-assisted laser desorption/ionization (MALDI mass spectrometry imaging) and immunohistochemistry to map cell type–specific metabolic remodeling in an experimental rat controlled cortical impact model during acute and subacute phases after injury.
The investigators administered isotopically labeled pyruvate in vivo and applied MALDI mass spectrometry imaging to tissue sections to detect spatial distributions of metabolites and their labeled isotopologues. Immunohistochemistry was used in parallel to identify regions enriched for particular cell types, chiefly microglia/macrophages and astrocytes, permitting correlation of metabolic patterns with neuroglial compartments. The work was performed in a controlled cortical impact rat model and examined the acute and subacute phases after injury.
TBI produced distinct, compartmentalized metabolic responses that evolved over time and differed by region. The study reports that metabolic signatures associated with inflammatory versus homeostatic or supportive functions segregated spatially: microglial/macrophage-rich regions and astrocyte-enriched areas exhibited different metabolite profiles and temporal dynamics. These observations indicate that secondary injury involves organized immunometabolic remodeling rather than a uniform metabolic perturbation across the injured cortex.
Regions enriched for microglia and macrophages selectively accumulated citrate, succinate, and itaconate. The pattern of elevated citrate and succinate, together with itaconate accumulation, is consistent with inflammatory metabolic rewiring in innate immune cells. These metabolites have been associated in other contexts with immune activation and altered TCA cycle handling, and their localized accumulation here suggests that microglia/macrophages undergo a defined inflammatory metabolic program in the injured brain.
In contrast, areas enriched for astrocytes showed increased abundance of glutamine and malate. This pattern points to remodeling of neuron–astrocyte metabolic coupling, including perturbation of the glutamate–glutamine cycle, and suggests enhanced anaplerotic metabolism in astrocytic compartments. The findings indicate astrocytes respond metabolically in a manner distinct from microglia/macrophages during the evolution of secondary injury.
A notable observation was that labeled isotopologues of selected metabolites—specifically glutamate and citrate derived from administered pyruvate—changed prior to detectable alterations in the corresponding total metabolite pools. This implies that flux through metabolic pathways can shift early after injury and can be detected by isotopic tracing before steady-state concentrations of metabolites are altered. Such early flux signatures may serve as sensitive indicators of metabolic remodeling and could inform timing for interventions or metabolic imaging strategies.
The compartmentalized, spatiotemporally evolving metabolic signatures described here identify candidate metabolic pathways that could be targeted to modify the course of secondary brain injury. Distinct metabolic states in microglia/macrophages versus astrocytes suggest cell type–specific intervention strategies may be required. Additionally, early changes in isotopologue labeling support the potential for metabolic imaging approaches that monitor flux to detect and monitor injury-related metabolic remodeling.
The source material summarized the experimental approach and principal findings but did not report full methodological details, quantitative results, sample sizes, statistical analyses, or specific timepoints and spatial maps in the abstract. Detailed experimental parameters, validation experiments, and translational or therapeutic testing were not reported in the abstract and would need to be consulted in the full preprint or supplementary material for comprehensive evaluation.
Collectively, these results map a spatiotemporal landscape of immunometabolic remodeling after acute TBI, reveal metabolically distinct responses in microglial/macrophage and astrocytic compartments during secondary injury, and highlight metabolic pathways and flux measures as candidate targets for therapy and metabolic imaging.